Cite
MLA Citation
Mark C Genovese et al.. “P171 Efficacy and safety of upadacitinib in patients with active PsA and inadequate response to biologic DMARDs (SELECT-PsA-2): a double-blind, randomised controlled Phase III trial.” Rheumatology, vol. 60, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100127520691.0x000043